17
Eversense XL CGM User Guide
2
Warnings (continued)
• High doses of aspirin (over 2000 mg), such as for chronic treatment of inflammatory conditions
(e.g., rheumatoid arthritis), may falsely lower Sensor glucose readings.
• Until it has healed, always cover the insertion site with a sterile bandage before placing the smart transmitter
adhesive over the sensor. Failure to do so could result in infection at the insertion site.
• Please review this User Guide with your healthcare professional. For additional Eversense XL product questions
and troubleshooting issues, contact Roche Diabetes Care at 0800-701000 (UK) or 1800-709600 (ROI).
• Always calibrate the system using only a fingerstick blood sample. DO NOT use an alternative site (such as
forearm or palm) blood glucose reading to calibrate the system.
• DO NOT insert your infusion set within 10.16 cm (4 in) of the sensor site. If the insulin delivery site is within
10.16 cm (4 in) of the sensor site, it may interfere with sensor glucose readings and can cause inaccurate
glucose readings.
• Always follow your doctor’s instructions for care after the sensor insertion or removal. Contact your doctor if
any of the following events occur:
– You have pain, redness, or swelling at the incision site(s) later than 5 days after the sensor insertion or
removal.